Regulatory roles and molecular mechanisms of N6-methyladenosine (m6A) modification in ischemia-reperfusion injury
- 1The First Clinical Medical College of Gansu University of Chinese Medicine, Lanzhou, Gansu, China
- 2School of Basic Medical Sciences, Gansu University of Chinese Medicine, Lanzhou, Gansu, China
- 3Department of Anesthesiology, Gansu Provincial Hospital of Traditional Chinese Medicine, Lanzhou, Gansu, China
Abstract
Background: N6-methyladenosine (m6A) represents a prevalent internal epitranscriptomic modification of mRNA that influences post-transcriptional gene regulation. Clinically, ischemia-reperfusion (I/R) injury contributes to tissue damage in acute kidney injury, ischemic stroke, and myocardial infarction, particularly after blood flow is restored.
Methods: We searched Google Scholar, Web of Science, and PubMed for literature published through May 2026. The retrieval focused on articles detailing how m6A effector proteins—specifically writers, erasers, and readers—mediate I/R pathogenesis within hepatic, renal, cardiac, and cerebral tissues.
Results: m6A-associated regulation influences RNA metabolism during I/R injury. Context-dependent changes in m6A regulators and target transcripts are linked to oxidative stress, inflammatory cascades, and specific programmed cell death pathways, including ferroptosis and pyroptosis, across various organ systems.
Conclusion: Profiling these organ-specific m6A molecular networks may inform future research on targeted epitranscriptomic interventions for IRI.
Related
- N6-Methyladenosine (m6A) RNA Modification in Periodontitis: Molecular Mechanisms and Therapeutic Potential: A Narrative Review
- Root morphogenetic responses to waterlogging stress in plants: from structural reconfiguration to molecular regulatory mechanisms
- Creatine metabolic network and host immune interplay: from molecular mechanisms to regulatory strategies
- Gene Regulatory Network Reconstruction to Decipher the Molecular Mechanisms Governing Bacteriocyte-Based Symbioses
- Cold Tolerance in Alfalfa: Physiological Mechanisms, Regulatory Networks, and Molecular Breeding Prospects.
BibTeX
@article{zhang2026regulatory,
title = {{Regulatory roles and molecular mechanisms of N6-methyladenosine (m6A) modification in ischemia-reperfusion injury}},
author = {Di Zhang and Wenjuan An and Xing Zhang and Yuhang Han and Guoxin Zhang and Lingyun Zhang},
journal = {PeerJ},
year = {2026},
month = nov,
doi = {10.7717/peerj.21875},
url = {https://peerj.com/articles/21875},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Regulatory roles and molecular mechanisms of N6-methyladenosine (m6A) modification in ischemia-reperfusion injury
AU - Di Zhang
AU - Wenjuan An
AU - Xing Zhang
AU - Yuhang Han
AU - Guoxin Zhang
AU - Lingyun Zhang
PY - 2026
DA - 2026/11/06
JO - PeerJ
DO - 10.7717/peerj.21875
UR - https://peerj.com/articles/21875
AB - Background: N6-methyladenosine (m6A) represents a prevalent internal epitranscriptomic modification of mRNA that influences post-transcriptional gene regulation. Clinically, ischemia-reperfusion (I/R) injury contributes to tissue damage in acute kidney injury, ischemic stroke, and myocardial infarction, particularly after blood flow is restored. Methods: We searched Google Scholar, Web of Science, and PubMed for literature published through May 2026. The retrieval focused on articles detailing how m6A effector proteins—specifically writers, erasers, and readers—mediate I/R pathogenesis within hepatic, renal, cardiac, and cerebral tissues. Results: m6A-associated regulation influences RNA metabolism during I/R injury. Context-dependent changes in m6A regulators and target transcripts are linked to oxidative stress, inflammatory cascades, and specific programmed cell death pathways, including ferroptosis and pyroptosis, across various organ systems. Conclusion: Profiling these organ-specific m6A molecular networks may inform future research on targeted epitranscriptomic interventions for IRI.
SN - 2167-8359
ER -